References
- Rosof BM. Allopurinol for sarcoid? N Engl J Med. 1976; 294:447.
- Brechtel B, Haas N, Henz BM, Kolde G. Allopurinol: A therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol. 1996;135:307–9.
- Pollock JL. Sarcoidosis responding to allopurinol. Arch Dermatol. 1980;116:273–4.
- Pfau A, Stolz W, Karrer S, Szeimies RM, Landthaler M. Allopurinol in der Behandlung der Kutanen Sarkoidose. Hautarzt. 1998;49:216–18.
- Samuel M, Allen GE, McMillan SC, Burrows D, Corbett JR, Beare JM. Sarcoidosis: initial results on six patients treated with allopurinol. Br J Dermatol. 1984;111:20.
- Voelter-Mahlknecht S, Benez A, Metzger S, Fierlbeck G. Treatment of subcutaneous sarcoidosis with allopurinol. Arch Dermatol. 1999;135:1560–1.
- El-Euch D, Mokni M, Trojjet S, Khouaja A, Ben Osman A. Sarcoidosis in a child treated succesfully with allopurinol. Br J Dermatol. 1999;140:1184–5.
- Antony F, Layton AM. A case of cutaneous acral sarcoidosis with response to allopurinol. Br J Dermatol. 2000;142:1052–3.
- Fanburg BL. Drug therapy reviews: Treatment of sarcoidosis. Am J Hosp Pharm. 1979;36:351–4.
- Kerdel FA, Moschella SL. Sarcoidosis, an updated review. J Am Acad Dermatol. 1984;1:1–16.
- Gawkrodger DJ. Sarcoidosis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling: Textbook of dermatology. Vol 3. 6th ed. Boston: Blackwell Science. 1998. P. 2679–702.
- Siltzbach LE. Sarcoidosis: Clinical features and management. Med Clin North Am. 1967;51:483–502.
- Mizuno K, Okamoto H, Horio T. Monocyte-derived multi- nucleated giant cells and sarcoidosis. J Dermatol Sci. 2003;31:119–28.
- Mizuno K, Okamoto H, Horio T. Inhibitory influences of xanthine oxidase inhibitor and angiotensin 1-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol. 2004;150:205–10.